GlassScriptPhysician profile
Martin C Masarech
NPI 1356341622
$13,911.99
in general payments reported to CMS, 2019-2025
33 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,198 · 2020: $1,603 · 2021: $3,428 · 2022: $2,782 · 2023: $1,558 · 2024: $851 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,901.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,776.02 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $1,939.23 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $1,712.32 | 2021-2024 | |
| Novo Nordisk INC | $1,393.77 | 2019-2024 | Ozempic, Rybelsus, Saxenda |
| Pfizer INC. | $1,080.50 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $764.89 | 2019-2023 | Stiolto Respimat, Spiriva Respimat |
| Janssen Pharmaceuticals, INC | $763.37 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $441.21 | 2019-2025 | Proquad, Gardasil 9, Capvaxive |
| Amarin Pharma, INC. | $411.63 | 2019-2021 | |
| Amgen INC. | $402.61 | 2019-2024 | Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $380.45 | 2019-2023 | Trintellix |
| Novartis Pharmaceuticals Corporation | $243.30 | 2019-2024 | |
| Astellas Pharma US INC | $241.55 | 2019-2021 | |
| Allergan, INC. | $229.17 | 2019-2020 | |
| Exact Sciences Corporation | $188.32 | 2023-2025 | Cologuard Collection Kit |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $161.25 | 2019-2025 | Mounjaro, Zepbound |
| Teva Pharmaceuticals USA, INC. | $110.27 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $108.53 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.63 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $88.45 | 2019 | |
| Si-Bone, INC. | $75.38 | 2019 | |
| Abbott Laboratories | $64.73 | 2020-2023 | Freestyle Libre 3 |
| Corium, LLC | $43.05 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.70 | 2021-2022 | |
| Eisai INC. | $25.87 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.03 | 2021 | |
| Sanofi Pasteur INC. | $23.47 | 2022 | |
| Dynavax Technologies Corporation | $20.26 | 2022 | |
| Grifols USA, LLC | $15.32 | 2020 | |
| Horizon Therapeutics Plc | $14.34 | 2019 | |
| Idorsia Pharmaceuticals US INC | $14.16 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.76 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Masarech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.